Stock screenerAll disclosures →
EDGAR →
LXRX
Conviction 100HealthcareScan · Thu, Jun 25, 2026LXRX$2.30+3.60%
ResistanceSupportVol 14Vol MA14 2.98M
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price2.30
Change+3.60%
Gap+0.68%
Rel volume5.27×
Avg volume2.73M
Avg $ vol5.65M
SMA 202.01
SMA 501.96
SMA 2001.55
Price vs 50+17.16%
Price vs 200+48.79%
MA stackbullish
50/200 cross—
Supertrendup · 1.91
RSI (14)68
MACD hist0.03
MACD crossbull · 3d
Stoch %K / %D86 / 86
ADX (14)20
+DI / −DI31 / 12
RSI divergence—
MACD divergence—
ATR %+5.70%
ADR %5.96%
52w high2.44
52w low0.8209
From 52w high-5.74%
Above 52w low+180.18%
New 52w highNo
SqueezeOff
Bollinger width27.58%
%B1.02
Donchian pos86.96%
Donchian high2.38
Donchian low1.80
AVWAP (52w high)2.14
vs AVWAP high+7.46%
AVWAP (52w low)1.45
vs AVWAP low+58.43%
OBV trendUp
Chaikin MF (20)-0.13
Today vs 20d5.27×
Avg vol (14d)2.98M
Avg vol (20d)2.73M
Avg $ vol (20d)5.65M
Market cap1.02B
RS 3m (vs SPY)+16.81%
RS 6m (vs SPY)+82.01%
RS line new highNo
Trend template8/8
Technical rank92.0
1 week+12.75%
1 month+11.65%
3 months+36.90%
6 months+88.52%
1 year+198.58%
YTD+101.75%
P/E-20.29
P/B5.04
P/S170.25
P/FCF-15.06
EPS-0.1400
Div yield—
ROE-24.82%
ROA-18.73%
Debt/Eq0.24
Current18.79
EV/EBITDA-21.40
Gross margin—
Net margin-838.88%
Rev growth440.63%
EPS growth74.88%
Price target5.03
Target upside118.70%
Analyst ratingBuy
Institutional75.47%
Ent. value1.03B
Revenue1.26M
Net income-1.04M
Gross profit—
Free cash flow-67.85M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out444.2M
Employees81
ListedFri, Apr 7, 2000
Free float158.98M
Float %43.7%
Short interest26.21M
Days to cover13.7d
Short volume45.4%
Squeeze score77 / 100
Next earningsWed, Aug 5, 2026 (41d)
EPS forecast−$0.05 · 2 est
Last EPS vs est$0.00 vs −$0.04
Last surprise+100.0% beat
Setup gradeA+
Conviction100 / 100
Pattern quality—
Tech rank92.0 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance2.41
Support1.66
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in LXRX
No recent disclosed trades by Congress in LXRX. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in LXRX · 6 buys · 3 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
BARKER SAM L Director · Restricted Stock Units · 2026-06-03 | Exercise | 89.31K | $0 | 2026-06-03 | 2026-06-04 |
BARKER SAM L Director · Common Stock · 2026-06-03 | Exercise | 89.31K | $0 | 2026-06-03 | 2026-06-04 |
DEBBANE RAYMOND Director · Common Stock · 2026-06-03 | Other | — | — | 2026-06-03 | 2026-06-04 |
SOBECKI CHRISTOPHER J Director · Common Stock · 2026-06-03 | Exercise | 89.31K | $0 | 2026-06-03 | 2026-06-04 |
Amouyal Philippe Director · Common Stock · 2026-06-03 | Exercise | 89.31K | $0 | 2026-06-03 | 2026-06-04 |
SOBECKI CHRISTOPHER J Director · Restricted Stock Units · 2026-06-03 | Exercise | 89.31K | $0 | 2026-06-03 | 2026-06-04 |
Sullivan Diane E. Director · Common Stock · 2026-06-03 | Exercise | 89.31K | $0 | 2026-06-03 | 2026-06-04 |
Amouyal Philippe Director · Restricted Stock Units · 2026-06-03 | Exercise | 89.31K | $0 | 2026-06-03 | 2026-06-04 |
DEBBANE RAYMOND Director · Common Stock · 2026-06-03 | Exercise | 89.31K | $0 | 2026-06-03 | 2026-06-04 |
Swain Judith L Director · Common Stock · 2026-06-03 | Exercise | 89.31K | $0 | 2026-06-03 | 2026-06-04 |
SEC filings
EDGAR filings in LXRX
No recent SEC filings on file for LXRX.
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.